Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicarbonate Administration in CKD
NCT02915601Completed
- Sponsor
- University of Colorado Denver
- Start
- Jan 2017
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic kidney disease (CKD) comparing Sodium Bicarbonate with Placebo (2 arms). Primary endpoints: Change in Brachial Artery Flow Mediated Dilation at 12 months and Change in Aortic Pulse Wave Velocity at 12 months. Started Jan 2017; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02915601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02915601.